肝脏 ›› 2019, Vol. 24 ›› Issue (8): 857-860.

• 论著 • 上一篇    下一篇

肝硬化相关急性肾损伤30天内死亡的相关因素分析

徐强, 马燕, 郭峰, 王晓波, 王晓忠   

  1. 830000 乌鲁木齐 新疆医科大学第四临床医学院肝病科
  • 收稿日期:2019-03-28 发布日期:2020-04-01
  • 通讯作者: 王晓忠,Email:wxz125@sina.com
  • 基金资助:
    国家自然科学基金(81760832)

Analysis of risk factors for 30-day death of cirrhosis-associated acute kidney injury

XU Qiang, MA Yan, GUO Feng, WANG Xiao-bo, WANG Xiao-zhong   

  1. Department of Liver Diseases, Traditional Chinese Medicine Hospital of Xinjiang Uygur Autonomous Region, Urumqi 830000, China
  • Received:2019-03-28 Published:2020-04-01
  • Contact: WANG Xiao-zhong, Email: wxz125@sina.com

摘要: 目的 本研究采用AKI最新诊断标准,分析肝硬化相关AKI 患者30 d内死亡的相关因素。方法 回顾性分析131例符合2015年ICA-AKI诊断标准的患者,随访30 d,分为死亡组和生存组,采用单因素、多因素分析影响肝硬化相关AKI患者30 d内死亡的重要因素。结果 131例患者中,死亡29例(22.14%),其中,AKI I期患者64例,死亡6例(20.69%),AKI Ⅱ期患者44例,死亡10例(34.48%),AKI Ⅲ期患者23例,死亡13例(44.83%);单因素分析结果显示,平均动脉压、肝肺综合征、原发性肝癌、WBC、 AST、TBil、CHE、INR、BUN、Cr、去甲肾上腺素(NA)、MELD与肝硬化相关急性肾损伤30 d死亡有关,OR值分别为:1.05、3.54、6.15、0.83、0.99、1.00、1.00、0.32、0.94、0.53、1.11、0.87(均P<0.05);多因素分析结果显示,原发性肝癌、WBC、INR、NA是肝硬化相关急性肾损伤30 d死亡的重要因素,OR值分别为:6.21、0.83、0.28、1.05(均P<0.05)。单因素与多因素分析均表明急性肾损伤III期肝硬化患者相比于I期具有更高的30 d病死率(OR值分别为:0.08、0.16,均P<0.05)。结论 肝硬化相关急性肾损伤患者,AKI分期越高,30 d死亡率越高。

关键词: 肝硬化, 急性肾损伤, 30天病死率

Abstract: Objective To analyze the risk factors for death within 30 days in patients with cirrhosis-associated acute kidney injury (AKI) according to the latest diagnostic criteria for AKI.Methods A total of 131 patients who met the 2015 International Club of Ascites-AKI diagnostic criteria were retrospectively analyzed. They were followed up for 30 days, and divided into the death and survival groups. Univariate and multivariate analyses were performed to identify important factors affecting 30-day mortality of cirrhosis-associated AKI patients. Results (1) During 30 days of follow-up, 29 (22.14%) patients died. Among all the patients, 64 with stage I AKI had a mortality rate of 20.69%, 44 with stage II AKI had a mortality rate of 34.48%, and 23 with stage III AKI had a mortality rate of 44.83%. (2) Univariate analysis showed that mean arterial pressure, hepatopulmonary syndrome, primary liver cancer, white blood cell (WBC) count, aspartate aminotransferase, total bilirubin, serum cholinesterase, the international normalized ratio (INR), blood urea nitrogen, creatinine, noradrenaline (NA) and end-stage liver disease score were correlated with 30-day death of cirrhosis-associated AKI, and the odds ratio (OR) values were 1.05, 3.54, 6.15, 0.83, 0.99, 1.00, 1.00, 0.32, 0.94, 0.53, 1.11 and 0.87, respectively (P<0.05). (3) Multivariate analysis showed that primary liver cancer, WBC count, INR and NA were important factors for 30-day death of cirrhosis-associated AKI, and the OR values were 6.21, 0.83, 0.28 and 1.05, respectively (P<0.05). (4) Both univariate and multivariate analyses indicated that patients with stage III cirrhosis-associated AKI had a higher 30-day mortality than those with stage I (OR: 0.08, 0.16, P<0.05).Conclusion For patients with cirrhosis, the higher the AKI stage, the higher the 30-day mortality.

Key words: Liver cirrhosis, Acute kidney injury, 30-day mortality